The prostacyclin receptor PTGIR is a NRF2-dependent regulator of CD8+ T cell exhaustion

Authors:

Abstract
CD8+ T cell exhaustion (Tex) limits immune control of cancer, but the underlying molecular drivers are unclear. In the present study, we identified the prostaglandin I2 (prostacyclin) receptor PTGIR as a cell-intrinsic regulator of T cell exhaustion. Transcriptomic profiling of terminally exhausted (Ttex) CD8+ T cells revealed increased activation of the nuclear factor erythroid 2-related factor 2 (NRF2) oxidative stress response pathway. Enhancing NRF2 activity (by conditional deletion of Kelch-like ECH-associated protein 1 (KEAP1)) boosts glutathione production in CD8+ T cells but accelerates terminal exhaustion. NRF2 upregulates PTGIR expression in CD8+ T cells. Silencing PTGIR expression enhances T cell effector function (that is, interferon-γ and granzyme production) and limits Ttex cell development in chronic infection and cancer models. Mechanistically, PTGIR signaling impairs T cell metabolism and cytokine production while inducing transcriptional features of Tex cells. These findings identify PTGIR as a NRF2-dependent immune checkpoint that regulates balance between effector and exhausted CD8+ T cell states.
Funding Information
  • Allen Family Philanthropies
  • Van Andel Institute
  • Gouvernement du Canada | Canadian Institutes of Health Research (MFE-403514, MFE-181903)
  • U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R21AI153997, AI154450, AI158294)
  • Cancer Prevention and Research Institute of Texas (RR210035)
  • University of Texas Southwestern Medical Center
  • U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG056524)
  • V Foundation for Cancer Research
  • American Federation for Aging Research
  • Cancer Research Institute

This publication has 58 references indexed in Scilit: